Acta Pharmaceutica Sinica B
|
2025, 15(11): 6076-6081
• Highlights •
Protein degradation-based anti-infective drug research
Full
Dazhou Shi1, Shujing Xu1,2, Xu Deng3,4, Yundong Sun2, Peng Zhan1
Affiliations
1 State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China;
2 Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Microbiology, School of Basic Medical Science, Shandong University, Jinan 250012, China;
3 Xiangya School of Pharmaceutical Science, Central South University, Changsha 410013, China;
4 Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, China
doi: 10.1016/j.apsb.2025.08.024
Outline
Protein degradation
/
Antimicrobial
/
Antimalarial
/
Antiviral
/
PROTAC
/
BacPROTAC
/
Drug resistance
/
Targeted therapy
Dazhou Shi, Shujing Xu, Xu Deng, Yundong Sun, Peng Zhan.
Protein degradation-based anti-infective drug research[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(11)
: 6076
-6081
.
DOI: 10.1016/j.apsb.2025.08.024
Year 2025 volume 15 Issue 11
PDF
5
3
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.08.024
- Receive Date:2025-06-18
- Online Date:2026-09-17